Adjusting eating patterns, movement habits, or sleep quality often helps
GDF-8: A New Era in Muscle Growth Therapies is Coming to Market On November 14, 2025, Scholar Rock released its third-quarter financial and pipeline update, announcing that it had held a constructive, face-to-face Type A meeting with the FDA regarding the BLA for its core asset, Apitegromab, intended for the treatment of spinal muscular atrophy (SMA) in both children and adults
EPO mimetics stimulate red blood cell production, potentially enhancing endurance performance by improving oxygen delivery to muscles
Terry Grossman, MD
Some may notice changes sooner, while others may see more gradual effects over time
Although hiccups are not listed amongst the most common adverse reactions in official prescribing information, there are plausible mechanisms linking Mounjaro's effects on gastric motility to this symptom